3201 |
District TB-comorbidity Coordination Committees [DTCC] |
25/10/2023 |
Admin related matters |
4370 |
District Tuberculosis Officer - DTO |
25/10/2023 |
Human resource management |
3462 |
DMC Register |
25/10/2023 |
NIKSHAY |
1289 |
DNA Extraction in TrueNAT MTB and TrueNAT MTB/RIF DX Assay |
25/10/2023 |
Laboratory services and management |
276 |
Do's & Don'ts for Patient Communication |
25/10/2023 |
Advocacy communication and social mobilization |
3706 |
Documentation for NHM auditing |
25/10/2023 |
NHM related matters |
3881 |
Documentation of MGIT Cultures |
25/10/2023 |
Laboratory services and management |
2422 |
Documenting the store visit |
25/10/2023 |
Monitoring and Evaluation |
4839 |
Documenting the Supervisory visit |
25/10/2023 |
Monitoring and Evaluation |
1952 |
Donning and Doffing of PPE |
25/10/2023 |
Laboratory services and management |
2625 |
Dosages of M/XDR-TB Drugs for Adult in Longer Oral M/XDR-TB Regimen |
25/10/2023 |
Drug resistant TB management |
1422 |
Dosing of Medicines Used in Second-line MDR-TB Regimens by Weight Band in Patients Under 15 Years |
25/10/2023 |
Drug resistant TB management |
87 |
DOTS Strategy |
25/10/2023 |
Adherence |
3421 |
Download the Tb Arogya Sathi App and Steps to Login |
25/10/2023 |
Digital interventions |
3281 |
DR TB with HIV Co-infection |
25/10/2023 |
Drug resistant TB management, Tb Comorbidities |
100 |
DR-TB Centres and Network |
25/10/2023 |
Drug resistant TB management, Admin related matters |
3203 |
DR-TB Counselling Register |
25/10/2023 |
Drug resistant TB management, Advocacy communication and social mobilization, NIKSHAY |
1099 |
DR-TB Service Referral Linkages Scenario 3: DR-TB Patient Referred for Treatment from the Private Sector with Bacteriological Confirmation in the Private Sector |
25/10/2023 |
Drug resistant TB management, Partnership and private sector engagement |
1100 |
DR-TB Service Referral Linkages Scenario 5: DR-TB Patient Referred for Treatment from the Private Sector with Treatment Initiated in the Private Sector |
25/10/2023 |
Drug resistant TB management, Partnership and private sector engagement |
1822 |
DR-TB Services and Functions of Stakeholders |
25/10/2023 |
Drug resistant TB management, Partnership and private sector engagement |
1098 |
DR-TB Services Referral Linkage Scenario 1: Patient Notified from the Private Sector |
25/10/2023 |
Drug resistant TB management, Partnership and private sector engagement |
631 |
DR-TB Treatment – Patient Flow |
25/10/2023 |
Drug resistant TB management |
1803 |
DR-TB Treatment Care Cascade |
25/10/2023 |
Drug resistant TB management |
1040 |
DR-TB Treatment in Pregnancy: General Considerations |
25/10/2023 |
Drug resistant TB management, Management of TB in pregnancy |
1862 |
DR-TB Treatment in Pregnancy: Recommendation for the Use of Contraception |
25/10/2023 |
Drug resistant TB management, Management of TB in pregnancy |
5 |
Advocacy Communication and Social Mobilisation |
26/10/2023 |
Advocacy communication and social mobilization |
5671 |
Success stories, learnings on ACSM for TB elimination |
26/10/2023 |
|
4566 |
Monitoring indicators for case finding |
04/12/2023 |
|
86 |
National TB Elimination Program [NTEP] |
04/12/2023 |
|
133 |
Patient and Process identifiers in Nikshay |
04/12/2023 |
|